Recent Finacing
Recent Raise
BioAegis Therapeutics is a clinical-stage biotech developing recombinant plasma gelsolin (rhu-pGSN) therapeutics and a pGSN biomarker diagnostic for infection- and inflammation-driven diseases, advancing clinical trials and scaling manufacturing.